Stocktoria
Ainos, Inc. AIMD
Ainos, Inc. (AIMD) earns a Piotroski F-score of 3/9 (weak financial health), with an Altman Z″ in the distress zone. It does not currently pay a dividend. FY2025 revenue was $124,157 at a -11897.0% net margin.
Quality score trend · recomputed for each fiscal year
Each year's score is computed from that year's filing — a rising Piotroski F or Altman Z″ means improving financial health, a fall is worth a look.
Beneish M-score: -2.62 — low (below −2.22 — no manipulation red flag) . A statistical screen for earnings manipulation, not proof — and it doesn't apply to most banks/insurers.
Smart money · insiders, last 12 months
Open-market insider purchases minus sells (SEC Form 4) — real buying with their own money is a bullish “smart money” signal; grants and option exercises are excluded.
How it ranks in Manufacturing · percentile among 1957 companies
Percentile vs other Manufacturing companies we cover — e.g. “stronger than 90%” means only 10% score higher on that measure.
Piotroski F breakdown · 3/9 tests passed
- Positive return on assets
- Positive operating cash flow
- Rising ROA
- Cash flow exceeds net income
- Lower long-term debt
- Rising current ratio
- No share dilution
- Rising gross margin
- Rising asset turnover
Altman Z″ components · distress zone
| Component | Value |
|---|---|
| Working capital / assets | 0.003 |
| Retained earnings / assets | -3.235 |
| EBIT / assets | -0.67 |
| Equity / liabilities | 0.568 |
Sector peers · similar-size Manufacturing companies compare side by side →
| Ticker | Company | Piotroski F | Altman Z″ | P / E | Revenue growth |
|---|---|---|---|---|---|
| AIMD | Ainos, Inc. | 3/9 | -14.44 | — | — |
| VTIX | Virtuix Holdings Inc. | 4/9 | — | — | — |
| LINK | INTERLINK ELECTRONICS INC | 3/9 | -9.55 | — | +1.8% |
| INVE | Identiv, Inc. | 2/9 | 10.97 | — | -19.3% |
| WETH | Wetouch Technology Inc. | 6/9 | — | 2.3 | +6.8% |
| TACT | TRANSACT TECHNOLOGIES INC | 4/9 | 6.19 | — | +18.7% |
| RDCM | RADCOM LTD | 7/9 | 8.07 | 18.7 | +17.2% |
About Ainos, Inc.
Ainos, Inc., a dual-platform company, focusing artificial intelligencebased smelltech technologies and immune therapeutics. It offers AI Nose, an AI-based electronic olfaction system, which uses a smell language model to digitize scent into Smell IDs and turning into machine-readable data. The company provides its platforms for semiconductor manufacturing, robotics, and smart manufacturing industries; as well as senior care and women's health sectors. In addition, it develops VELDONA, a low-dose oral interferon platform for human and animal health applications, targeting rare, autoimmune, and infectious diseases. The company was formerly known as Amarillo Biosciences, Inc. and changed its name to Ainos, Inc. in May 2021. Ainos, Inc. was incorporated in 1984 and is based in Houston, Texas. Ainos, Inc. is a subsidiary of Taiwan Carbon Nano Technology Corporation.
FAQ
Is AIMD financially healthy?
Ainos, Inc.'s Piotroski F-score is 3/9 (8–9 is excellent, 0–3 weak), and its Altman Z″ distress score is in the distress zone.
Does AIMD pay a dividend?
No, Ainos, Inc. does not currently pay a dividend.
How profitable is AIMD?
In FY2025, Ainos, Inc. had a net margin of -11897.0% and a return on equity of -195.3%.
Is AIMD a good stock to buy?
Stocktoria doesn't give buy or sell advice, but here is the data on Ainos, Inc.: a Piotroski F-score of 3/9, an Altman Z″ in the distress zone. Weigh these quality and valuation signals against your own goals.
Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.